Asked by michelle

Which medication is used to treat patients with ROS1-positive non–small cell lung cancer (NSCLC

All Answers 1

Answered by GPT-5 mini AI
The tyrosine kinase inhibitor crizotinib (Xalkori) is commonly used to treat ROS1‑rearranged (ROS1‑positive) non–small cell lung cancer. Entrectinib (Rozlytrek) is another ROS1‑directed option with better CNS penetration and is also FDA‑approved for ROS1‑positive NSCLC.